Contract 75N93019C00056
Crestone, Inc. · Department Of Health And Human Services · August 1, 2024
Crestone, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 1, 2024 for $9.28 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boulder, CO. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on June 16, 2026. If all options are exercised, the contract could reach $33.29 million.
Contract details
- PIID
- 75N93019C00056
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Boulder, CO
- First action
- August 1, 2024
- Latest action
- June 16, 2026
Description
TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.
Modification timeline
-
June 16, 2026Mod P00016 · Change Order$33.29M
-
June 25, 2025Mod P00014 · Funding Only Action$31.94M
-
August 1, 2024Mod P00011 · Exercise An Option$28.04M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019C00056?
Contract 75N93019C00056 is a federal contract awarded to Crestone, Inc. by Department Of Health And Human Services on August 1, 2024 for $9.28 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75N93019C00056?
Crestone, Inc. won contract 75N93019C00056 from Department Of Health And Human Services.
How much is contract 75N93019C00056 worth?
Contract 75N93019C00056 has obligated $9.28 million to date, with a total potential value of $33.29 million if all options are exercised.